Breaking News Bar

Business News and Information

BRIEF-Sanuwave Receives FDA De Novo Decision To Immediately Market Dermapace System For Treatment Of Diabetic Foot Ulcers In U.S.

* SANUWAVE RECEIVES FDA DE NOVO DECISION TO IMMEDIATELY MARKET THE DERMAPACE SYSTEM FOR THE TREATMENT OF DIABETIC FOOT ULCERS IN THE U.S. Source text for Eikon: Further company coverage:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear